REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

Clinical Trial ID NCT00378352

Rank	Title	Journal	Year	PubWeight™‹?›
1	Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.	JAMA	2011	4.09
2	New avenues of exploration for erythropoietin.	JAMA	2005	3.23
3	Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.	Am J Cardiol	2010	2.52
4	A novel protective effect of erythropoietin in the infarcted heart.	J Clin Invest	2003	2.32
5	An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.	Cardiovasc Res	2004	1.30
6	Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.	J Am Coll Cardiol	2010	1.17
7	Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.	Am Heart J	2010	1.00
8	Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.	J Nephropathol	2013	0.96
9	EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy.	J Thromb Thrombolysis	2013	0.81
10	Adjuvant cardioprotection in cardiac surgery: update.	Biomed Res Int	2014	0.81
11	Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.	Am Heart J	2009	0.76